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Abstract It is claimed that wound closure with 2-octyl-
cyanoacrylate has the advantages that band-aids are not
needed in the postoperative period, that the wound can get
in contact with water and that removal of stitches is not
required. This would substantially enhance patient comfort,
especially in times of reduced in-hospital stays. Postoperative
wound infection is a well-known complication in spinal
surgery. The reported infection rates range between 0% and
12.7%.Thequestionarisesiftheadvantagesofwoundclosure
with 2-octyl-cyanoacrylate in spinal surgery are not surpassed
byanincreaseininfectionrate.Thisstudyhasbeenconducted
toidentifytheinfectionrateofspinalsurgeryifwoundclosure
was done with 2-octyl-cyanoacrylate. A total of 235 patients
with one- or two-level surgery at the cervical or lumbar spine
were included in this prospective study. Their pre- and
postoperative course was evaluated. Analysis included age,
sex, body mass index, duration and level of operation, blood
examinations, 6-week follow-up and analysis of preoperative
risk factors. The data were compared to infection rates of
similar surgeries found in a literature research and to a
historical group of 503 patients who underwent wound
closure with standard skin sutures after spine surgery. With
the use of 2-octyl-cyanoacrylate, only one patient suffered
frompostoperativewoundinfectionwhichaccountsforatotal
infection rate of 0.43%. In the literature addressing infection
rate after spine surgery, an average rate of 3.2% is reported.
Infectionratewas2.2%inthehistoricalcontrolgroup.Norisk
factor could be identified which limited the usage of 2-octyl-
cyanoacrylate. 2-Octyl-cyanoacrylate provides sufficient
wound closure in spinal surgery and is associated with a low
risk of postoperative wound infection.
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Introduction
Postoperative wound infection is a well-recognised com-
plication in surgical procedures. In spinal surgery, postop-
erative infection rates were recorded between 0% and
12.7% [2, 4, 10–12, 18, 19, 23, 25, 29–31, 34, 35, 37, 39].
Postoperative wound infections cause discomfort for the
patient, which may lead to a second operation, long-term
use of antibiotics or prolongation of hospitalisation and
additional costs to the health care system [5].
The use of 2-octyl-cyanoacrylate (Dermabond, Ethicon,
Johnson & Johnson Medical GmbH, Norderstedt, Germany)
forwoundclosure has beenwidelydescribedbefore.Itisused
in facial surgery [7, 9], craniotomy or craniectomy [6],
corneal surgery [22], repairing of peripheral nerves [27],
orthopaedic surgery [21], neck surgery [29], hand surgery
[16] or mammoplasties [33], just to name a few recently
published studies. According to these studies, the use of
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DOI 10.1007/s10143-010-0258-52-octyl-cyanoacrylate allows wound management without
any band-aids, even if the wound would possibly get in
contact with water. Furthermore, removal of stitches is not
required, alleviating at least one patient–surgeon contact. Up
to date, the experience with the use of 2-octyl-cyanoacrylate
in spinal surgery is very limited [15], especially if risk
factors and the course of operation are additionally
addressed.
In the present study, 2-octyl-cyanoacrylate was used for
wound closure in one- and two-level spinal surgery cases.
The study was designed as a cross-sectional study to record
the incidence of wound infections after spine surgery. In
addition, limitations and risk factors for the use of 2-octyl-
cyanoacrylate were investigated.
Materials and methods
Patients
Two hundred thirty-five consecutive patients (136 men, 99
women; median age 60 years, range 25–84 years) were
recruited in this prospective clinical study. All patients who
underwent one- or two-level surgery at the cervical or
lumbar spine were included. Previous surgery, systemic
diseases or emergency surgeries were no exclusion criteria.
Every operation was done with the aid of an operating
microscope. Two hundred thirteen patients (90.6%) were
available for 6-week follow-up.
Fifty patients (21.3%) each underwent surgery at the
cervical spine for one- or two-level ventral fusion. Fifty
patients (21.3%) underwent lumbar disc surgery; 49
(20.1%) and 31 patients (13.2%) had surgery for one-level
and two-level lumbar stenosis, respectively. In five patients
(2.1%), re-operation for recurrent lumbar disc disease was
performed (Table 1). Thus, the length of the skin incision
was between 3 and 6 cm in the vast majority of the patients.
Two hundred twenty-three patients (94.4%) received
perioperative prophylactic antibiotic therapy with cefazolin
(2 or 4 g), 11 patients (4.7%) with clindamycin (0.6 or
0.9 g) and one patient (0.4%) was treated with amoxicillin
(1.0 g). The following additional data were recorded:
patients’ age, body mass index (BMI), duration of
operation, usage of wound drainage, pre- and postoperative
laboratory analysis, preexisting diseases, wound condition
and 6-week follow-up.
The data were compared to infection rates of similar
surgeries found in a literature research (Table 4) and to a
historical group of 503 patients, who underwent spine
surgery and standard sutured skin closure at our institution.
Four hundred and forty of the 503 patients (87.5%) were
operated on for cervical (n=62), thoracic (n=2) or lumbar
disc disease (n=338), 38 patients for recurrent disc disease,
22 patients for lumbar stenosis (4.4%), 30 patients (6.0%)
for epidural spinal tumour and 11 patients (2.2%) for spinal
fractures. Those data had been published in a doctoral
thesis regarding the postoperative wound infection rate with
and without perioperative antibiotic prophylaxis in cranial
and spinal operations [32].
Wound closure and postoperative wound management
Wound closure was performed with 2-octyl-cyanoacrylate
in all cases. After placing subcutaneous sutures for wound
adaptation and approximation of the skin edges, 2-octyl-
cyanoacrylate was applied for skin adhesion. After crushing
the inner ampoule, 2-octyl-cyanoacrylate was pumped into
the applicator and finally applied to the adapted wound
edges in multiple layers. Its liquid form polymerised to
solid form after 2–3 min (Fig. 1). The wound was covered
with a band-aid to avoid adherence to bedding layers. The
band-aid was removed on the first postoperative day, no
further band-aids were used. Approximately after 1 week,
2-octyl-cyanoacrylate automatically dissoluted. The
patients were allowed to take a shower on the first
postoperative day. As removal of stitches was not required,
the patients were not advised to seek again medical contact
for wound care.
Statistical analysis
Statistical analysis had been performed using Statistica
Version 8 (Statsoft Software Hamburg, Germany). Statistical
significance was defined as p<0.05.
Table 1 Types and course of operation
Cervical spine n %
Cervical spine 100 43%
One level 50 21%
Two level 50 21%
Lumbar spine n %
Herniated disc disease 55 23%
First operation 50 21%
Recurrent 5 2%
Stenosis 80 34%
One level 49 21%
Two level 31 13%
Duration
Average duration (min) 106.5
Range (min–max) 33–489
Wound drainage n %
Yes 157 67%
Six-week follow-up n %
Regular wound condition 134 100%
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In 235 patients, skin closure was performed with 2-octyl-
cyanoacrylate after anterior cervical (n=100) and dorsal
lumbar (n=135) spinal surgery. The average duration of
operation was 106.5 min (range 33–489 min) (Table 1). In
157 patients (67%), wound drainage was used for 1 day. The
patients’ average BMI was 28 (range 18–49). Coexisting
diseases were high blood pressure (49%; n=114), smoking
(24%; n=57), diabetes mellitus (17%; n=40), chronic
obstructive lung disease (7%; n=17), cardiac insufficiency
(3%; n=8) and malignant tumours (3%; n=8) (Table 2). No
foreign-body reaction occurred; wound conditions had been
regular with satisfactory cosmetic results in all patients that
were available for 6-week follow-up (90.6%).
Age (p=0.254) as well as arterial hypertension (p=
0.304) did not show statistical significance as risk factors in
cases of wound closure with 2-octyl-cyanoacrylate.
The overall infection rate was 0.43% with only one 79-
year-old female patient developing wound infection with
Staphylococcus aureus after one-level decompression for
lumbar spinal stenosis (Table 3). Duration of operation was
63 min. The laboratory analysis after decompression only
revealed slightly elevated infection parameters (c-reactive
protein of 27 mg/dl) and leucocytes on a regular basis. The
only preexisting disease had been high arterial blood
pressure. The patient’s BMI was within regular ranges
(BMI=25). She underwent wound revision with an un-
eventful course after the second operation.
Overall infection rate in the historic control group after
spinal surgery including cervical, thoracic and lumbar
spinal procedures was 2.8% without perioperative antibiotic
treatment and 2.2% with perioperative antibiotic treatment
(single-shot antibiotic treatment with either cephazolin,
clindamycin or ampicillin). In the literature addressing
infection rates after spine surgery, an average rate of 3.2%
has been reported (Table 4).
Discussion
In 1959, Coover et al. originally reported the chemistry and
performance of cyanoacrylate and its use as tissue adhesive
Fig. 1 Use of 2-octyl-cyanoacrylate (Dermabond®). After crushing
the inner ampoule (a), Dermabond is being pumped into the applicator
(b) and finally applied to the adapted wound edges in multiple layers
(c). Its liquid form polymerises rapidly to solid form (illustration
provided by Ethicon, Inc.)
Table 2 Patient population
Age
Average age (years) 60.4
Range 25–84
Gender n %
Female 99 42.1%
Male 136 57.9%
Risk factors n %
Diabetes 40 17%
Heart insufficiency 8 3%
Obstructive lung disease 17 7%
Chronic infections 0 0%
Malignoma 8 3%
Hypertonic disease 114 49%
Smoker 57 24%
BMI
Average BMI 28.0
Range 18–49
Neurosurg Rev (2010) 33:483–489 485for surgical procedures [8]. In the beginning, a long-chained
octyl-2-cyanoacrylate tissue adhesive was compared to two
short-chained ethyl-2- and butyl-2-cyanoacrylates. Skin
samples (pig model) were tested for the tensile strength of
their wound stability, and cell culture tests were used to
show the toxic effects of the three cyanoacrylates. In a
copper test, 2-octyl-cyanoacrylate was more stable than
ethyl- and butyl-cyanoacrylates. Breaking strength was
30% lower 28 days after operation with the new product
than with sutures. In electron microscopy, 2-octyl-
cyanoacrylate showed no disadvantages with regard to tissue
regeneration and no histotoxicity [24]. In 1998, the Food and
Drug Administration approved n-2-butylcyanoacrylate as 2-
octyl-cyanoacrylate [6, 13].
Regarding patients’ comfort, 2-octyl-cyanoacrylate the-
oretically offers several advantages. There is no need for
band-aids or waterproof band-aids for showering and no
removal of sutures or staples is required. Since its
introduction, numerous applications have been described
[6, 7, 9, 15, 16, 21, 22, 26, 28, 33, 38]. It is used in facial
surgery [7, 9, 38], craniotomy or craniectomy [6], corneal
surgery [22], repairing of peripheral nerves [26], orthopae-
dic surgery [21], neck surgery [28], hand surgery [16]o r
mammoplasties [33], just to name a few recently published
studies. Ellis et al. compared the use of fibrin glue and 2-
octyl-cyanoacrylate in facial plastic and reconstructive
surgery and concluded that cyanoacrylate is the ideal tissue
adhesive for surface cutaneous wound closure in regards to
safety, reliability, tensile strength and cost effectiveness [9].
Hancock et al. performed a prospective observational study
of the use of 2-octyl-cyanoacrylate in hand surgery. Wound
complication rate was low (one adverse event) and all
patients were satisfied (46%) or very satisfied (54%) with
wound healing and the cosmetic result. They concluded that
routine postoperative wound review in these patients might
not be needed, thereby saving time and resources [16].
S c o t te ta l .[ 33] reviewed 255 consecutive bilateral
reduction mammoplasties performed by a single surgeon
with 2-octyl-cyanoacrylate used for skin closure and
compared those data with an earlier review of 415 reduction
mammoplasties using standard sutured skin closures. 2-
Octyl-cyanoacrylate was associated with decreased opera-
tive times, a decreased rate for minor (1.18%) and major
wound dehiscence (0.78%) and less hypertrophic scar
revisions (2.75%).
Wilson and Mercer compared the use of 2-octyl-
cyanoacrylate with thin adhesive strips (Steri-Strips
TM)i n
unilateral cleft lip repair. They found a lower infection and
revision rate and a similar hypertrophic scar rate when 2-
octyl-cyanoacrylate was used [38].
Wang et al. have described the first clinical use of 2-
octyl-cyanoacrylate for wound closure in neurosurgical
procedures in paediatric neurosurgery [36].
Since spinal surgical interventions cannot be compared
with corneal surgery, mammoplasties, facial surgery or
craniotomies regarding postoperative wound infections, the
question arises if the benefits of 2-octyl-cyanoacrylate are
being outweighted by an increasing risk of surgical site
infections. Especially in lumbar spinal surgery, patients
often present with an exalted BMI with increased perspi-
ration, which are well-known factors closely related to a
higher number of wound healing abnormalities [1, 14, 17,
18, 20, 21, 25]. In addition, rest in supine position on the
wound after lumbar spine surgery has the potential leading
to the formation of humid chambers which can result in
wound breakdown and infection. Thus, it seems possible
that the patients who underwent spine surgery do not
benefit from the advantages of 2-octyl-cyanoacrylate and
that its use is especially contraindicated in patients who
have co-morbidities such as diabetes mellitus or hyperten-
Table 3 Occurrence of postoperative wound infection in cervical and lumbar spinal surgery
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486 Neurosurg Rev (2010) 33:483–489sion which are well-known risk factors of postoperative
infections [10, 11, 34, 39].
Former studies have demonstrated wound infection rates
after spinal surgery between 0% and 12.7%, with a mean
infection rate of 3.2% [2, 4, 10, 12, 18, 19, 23, 25, 29, 31,
34, 35, 37, 39] as demonstrated in Table 4. With an
infection rate of 0.43%, our results clearly demonstrate that
even patients with a high BMI and further risk factors do
not have an increased risk of postoperative wound
infections, once 2-octyl-cyanoacrylate is being used for
wound closure (Table 3). Possibly, the low infection rate of
2-octyl-cyanoacrylate is the result of antimicrobial proper-
ties against gram-positive organisms [27] and/or of the
sterile and occlusive liquid cover of 2-octyl-cyanoacrylate
[3] which prevents the formation of humid compartments.
This is supported by the finding that the infection rate was
substantially lower in the 2-octyl-cyanoacrylate group
(0.43%) than in the historical control group, in which
standard suture skin closure was performed (2.2%) [32].
Since we limited our study to the use of 2-octyl-
cyanoacrylate in spinal surgical procedures, we cannot
make a statement on its use in other neurosurgical
procedures. However, good results have been reported in
paediatric neurosurgery and craniotomy or craniectomy [6,
36]. Further studies are needed to make clear statements on
the use of 2-octyl-cyanoacrylate in cranial neurosurgical
procedures compared to standard suture skin closure.
Furthermore, the study does not allow to define up to
which lengths of skin incision 2-octyl-cyanoacrylate is an
effective and safe alternative to sutures, as the vast majority
of patients have had skin incisions between 3 and 6 cm.
We cannot definitively prove that the low infection rate
is attributable to the use of 2-octyl-cyanoacrylate, but our
results demonstrate the advantages of this liquid wound
closure with a low rate of surgical site infections, even in
patients with risk factors for surgical interventions.
Table 4 Characteristics of the selected analyses on antibiotic prophylaxis in the prevention of surgical site infections in neurosurgical procedures
Series (ref. no.) Study design No. of patients Antibiotic prophylaxis Infection rates
Mastronardi et al. [23] Prospective study
(microdiscectomy)
450 (group 1) Group 1: cephazolin+rifamycin Group 1: 0.67%
705 (group 2) Group 2: ampicillin+sulbactam Group 2: 0.69%
Olsen et al. [25] Retrospective case–control
study (laminectomy and/or
spinal fusion)
219 Different antibiotic regimen 2.8%
Weinstein et al. [38] Retrospective analysis (single
surgeon, spinal surgery)
2,391 Cephalothin or vancomycin 1.9%
Fang et al. [37] Retrospective case–control
study (spinal surgery)
1,629 First generation cephalosporin
(continued for 48 h, except in
simple spinal decompression)
4.4%
Blam et al. [4] Retrospective analysis
(elective spinal surgery
and spinal injury)
256 (patients with
spinal injury)
Not specified 9.4% (spinal injury)
2,990 (elective
spinal surgery)
3.7% (elective surgery)
Schnöring et al. [32] Retrospective analysis
(lumbar disc surgery)
963 Group 1: cefotiam Group 1: 0.2%
Group 2: no antibiotics Group 2: 2.8%
Rubinstein et al. [30] Double-blinded randomised
study (lumbar spinal surgery)
166 Group 1: cephazolin 1 g Group 1: 4.3%
Group 2: placebo Group 2: 12.7%
Takahashi et al. [34] Prospective study (spinal surgery) 1,415 Group 1: ABP for 7 days (postop) Group 1: 2.6%
Group 2: periop and 5 days postop Group 2: 0%
Group 3: periop and 3 days postop Group 3: 0%
Group 4: periop and 2 days postop Group 4: 0%
Valentini et al. [36] Prospective clinical series
(neurosurgical procedures)
1,747 (663 spinal
operations)
Four categories: 0.72% (0.15% in
spinal operations) Clean: cephazolin
Clean-contaminated:
cephazolin+metronidazole
Ventriculoperitoneal shunt
Other procedures
ABP antibiotic prophylaxis
Table 4 shows the characteristics of a selected series of published articles concerning postoperative wound infections in spinal procedures. Wound
infection rates were between 0% and 12.7%. Mean infection rate has been calculated as 3.2%. Data show the type of antibiotic prophylaxis, type
of study, number of patients included and the individual infection rate
Neurosurg Rev (2010) 33:483–489 487Strengths and limitations of the study
The strengths of the present study are the non-selective
inclusion of consecutive patients with cervical and lumbar
spinal degenerative disease and the prospective data collec-
tion. The major limitation is that the comparison of the
infection rate in the present series was only possible with an
institutional historical series and with the literature. The
decision to switch from sutures to 2-octyl-cyanoacrylate was
made on economical criteria. A randomised trial is needed to
underline the convincing results of the present study.
Conclusion
2-Octyl-cyanoacrylate provides sufficient wound closure in
spinal surgery and is associated with a low risk of
postoperative wound infection.
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Comments
Ralf A. Kockro, Zurich, Switzerland
This is an interesting report about the experiences with 2-octyl-
cyanoacrylate for wound closure in cervical and lumbar surgery. In
235 consecutive patients operated on in one institution, the authors
report one case (0.43%) of postoperative wound infection and overall
a good cosmetic outcome. This is an excellent result compared to the
commonly reported infection rate of approximately 3%, and it
approximately halves the infection rate of my own experiences with
“Steri-Strip” wound closure for one-level lumbar spinal surgery.
Technological advances offer chances of significant treatment benefits
and are worthy of bias-free evaluation. Once the results are verified in
larger series, this technique has good chances to be adopted broadly.
Claudius Thomé, Innsbruck, Austria
Dr. Wachter et al. present a monocentric prospective study on the
use of 2-octyl-cyanoacrylate in 235 consecutive patients treated by
mono- or bisegmental anterior cervical or posterior lumbar spine
surgery. The infection rate of 0.4% compares favourably to literature
data and to an infection rate of 2.2% found in a historical control
group of 503 patients with standard suture-based wound closure at the
same institution. All patients available for 6-week follow-up (90.6%)
demonstrated a satisfactory cosmetic result.
The authors report convincing results of a simple and intelligent
study. Obviously, this is not a randomized controlled trial, but with a
substantial number of patients collected consecutively it provides
evidence that this is a valid alternative to sutures. 2-octyl-cyanoacry-
late has been regularly used in other surgical disciplines and by many
spine surgeons due to the obvious advantages particularly for patient
comfort. The authors are to be congratulated for their prospective
analysis of spine cases.
Nevertheless, it has to be stressed that the patient cohort is limited
to small incisions, extradural procedures and particular regions.
Posterior cervical procedures have not been included. In my personal
experience, 2-octyl-cyanoacrylate in posterior cervical surgery tends
to produce somewhat wider scars, which may be due to the increased
tension on the respective skin upon motion. The lack of a structured
evaluation of the cosmetic result represents one limitation of the
present study. It should be also mentioned that the use of 2-octyl-
cyanoacrylate requires more meticulous suturing of the subcutaneous
layer to perfectly align the skin edges. Overall, however, this study
adds important and practical data to the literature.
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